Search

everythinglearnresearchcommunity

for

Search:↓

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Finasteride and analogues separated using LC-MS-MS technique.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Trazodone might help reverse post finasteride syndrome.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

CEC levels may be a useful marker for predicting prostate cancer progression.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.